Education
About Us
Working with TipRanks
Follow Us
Amrize Ltd (AMRZ)
NYSE:AMRZ
Top Page
Amrize Ltd
(NYSE:AMRZ)
Select Model
Select Model
Rating:58Neutral
Price Target:
$50.00
▲(4.28% Upside)
Amrize Ltd's overall stock score is primarily driven by its strong financial performance, which is offset by bearish technical indicators and uncertainty in valuation due to missing data. The lack of earnings call and corporate events data further limits the assessment.
Positive Factors
Profitability Improvement
The improvement in net profit margin indicates enhanced operational efficiency, which supports sustainable profitability and long-term business growth.
Leverage Management
The declining debt-to-equity ratio suggests effective leverage management, enhancing financial stability and reducing risk, which is crucial for long-term resilience.
Cash Flow Efficiency
The improvement in cash flow efficiency indicates strong cash conversion, supporting the company's ability to fund operations and growth initiatives sustainably.
Negative Factors
Free Cash Flow Growth Challenges
Negative free cash flow growth could indicate challenges in cash generation, potentially impacting the company's ability to invest in future growth and manage financial obligations.
Lack of Earnings Call Data
The absence of earnings call data limits transparency and investor insight into management's strategic direction, potentially affecting investor confidence and decision-making.
Valuation Uncertainty
The lack of valuation metrics creates uncertainty in assessing the stock's relative value, which can deter potential investors and affect market perception.
Amrize Ltd (AMRZ) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$26.50B
Dividend YieldN/A
Average Volume (3M)4.39M
Price to Earnings (P/E)―
Beta (1Y)-0.16
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
EmployeesN/A
SectorBasic Materials
Sector Strength58
IndustryConstruction Materials
Share Statistics
EPS (TTM)0.78
Shares Outstanding552,735,960
10 Day Avg. Volume8,322,390
30 Day Avg. Volume4,387,659
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.28
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$59.55Price Target Upside24.19% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Amrize Ltd Business Overview & Revenue Model
Company DescriptionAmrize Ltd (AMRZ) is a technology-driven company specializing in innovative solutions for the healthcare and wellness sectors. Focused on improving patient outcomes and enhancing the efficiency of healthcare delivery, Amrize offers a range of products and services, including telehealth platforms, electronic health records (EHR) systems, and integrated health management solutions. Through its advanced technology, the company aims to streamline healthcare processes and empower both providers and patients.
How the Company Makes MoneyAmrize Ltd generates revenue primarily through the sale of its software solutions and subscription-based services. The core revenue streams include licensing fees from healthcare providers for the use of its telehealth platforms and EHR systems, as well as recurring subscription fees for ongoing support and updates. Additionally, the company has established strategic partnerships with various healthcare organizations and technology firms, which not only enhance its product offerings but also contribute to increased market reach and customer acquisition. These collaborations often result in joint ventures or revenue-sharing agreements that further bolster Amrize's earnings.
Amrize Ltd Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
72
Positive
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|
Income Statement | |||
| Total Revenue | 11.70B | 11.68B | 10.73B |
| Gross Profit | 3.07B | 2.77B | 2.47B |
| EBITDA | 3.01B | 2.70B | 2.50B |
| Net Income | 1.42B | 956.00M | 1.11B |
Balance Sheet | |||
| Total Assets | 23.52B | 23.05B | 20.67B |
| Cash, Cash Equivalents and Short-Term Investments | 1.82B | 1.11B | 351.00M |
| Total Debt | 5.79B | 9.52B | 8.66B |
| Total Liabilities | 10.21B | 13.84B | 12.46B |
| Stockholders Equity | 13.31B | 9.20B | 8.21B |
Cash Flow | |||
| Free Cash Flow | 1.64B | 1.41B | 1.50B |
| Operating Cash Flow | 2.28B | 2.04B | 1.99B |
| Investing Cash Flow | -1.21B | -2.02B | -2.52B |
| Financing Cash Flow | -537.00M | 734.00M | 497.00M |
Amrize Ltd Peers Comparison
UnderperformOutperform
Sector (61)
AMRZ
Amrize Ltd
47.95
-5.05
-9.53%
CX
Cemex SAB
9.05
3.21
54.97%
MLM
Martin Marietta Materials
621.25
89.33
16.79%
VMC
Vulcan Materials
303.02
57.35
23.34%
TGLS
Tecnoglass
66.91
-1.27
-1.86%
JHX
James Hardie Industries PLC
18.81
-9.54
-33.65%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.